Company records / aulosbio.com

Aulos Bioscience

Aulos Bioscience (aulosbio.com): 1 change recorded in its website history since January 2021. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

HiringBetween 22 September 2021 and 16 January 2022
Added a careers page.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation

First recorded website

Observed 8 January 2021

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

A new direction for IL‑2 in immuno‑oncology

Homepage

Funding statements on the website: The founder of three biotech companies, Yanay has raised over $100 million from top venture capitalists and strategic investors.

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

July 2023 – November 2026 · 9 captures · latest observed messagingBoosting Immunity and Restoring Hope
Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.
This wording observed 6 November 2026.
current websiteHistorical capture not publicly available
Inspect 9 captures in this group
- 10 July 2023 · Boosting Immunity and Restoring Hope archived page
- 3 January 2024 · Boosting Immunity and Restoring Hope archived page
- 16 July 2024 · Boosting Immunity and Restoring Hope archived page
- 18 July 2025 · Boosting Immunity and Restoring Hope archived page
- 12 January 2026 · Boosting Immunity and Restoring Hope archived page
- 21 April 2026 · Boosting Immunity and Restoring Hope archived page
- 2 October 2026 · Boosting Immunity and Restoring Hope archived page
- 5 November 2026 · Boosting Immunity and Restoring Hope current websiteHistorical capture not publicly available
- 6 November 2026 · Boosting Immunity and Restoring Hope current websiteHistorical capture not publicly available
January 2022 – January 2023 · 2 capturesRevolutionizing cancer care through IL2 therapeutics | Aulos Bioscience
Aulos Bioscience is a immuno-oncology company revolutionizing cancer care through the development of best-in-class IL-2 therapeutics. Learn more.
This wording observed 22 January 2023.
archived page
Inspect 2 captures in this group
- 16 January 2022 · Revolutionizing cancer care through IL2 therapeutics | Aulos Bioscience archived page
- 22 January 2023 · Revolutionizing cancer care through IL2 therapeutics | Aulos Bioscience archived page
January 2021 – September 2021 · 2 capturesA new direction for IL‑2 in immuno‑oncology
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
This wording observed 22 September 2021.
archived page
Inspect 2 captures in this group
- 8 January 2021 · A new direction for IL‑2 in immuno‑oncology archived page
- 22 September 2021 · A new direction for IL‑2 in immuno‑oncology archived page

Cite this record

StartupHistory, “Aulos Bioscience” company record, https://startuphistory.org/c/aulosbio.com

Machine-readable: /c/aulosbio.com.json. How changes are found: method.